﻿<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>BioSpectrum Asia - RSS Feed</title>
    <link>http://biospectrumasia.ciol.com/rss/</link>
    <description>BioSpectrum Asia is a specialized information platform for life science articles in the Asia Pacific that includes life sciences articles, pharma news, life science products reviews and other information</description>
    <language>en-us</language>
    <pubDate>3/10/2010 5:30:07 PM</pubDate>
    <lastBuildDate>3/10/2010 5:30:07 PM</lastBuildDate>
    <docs>http://biospectrumasia.ciol.com/rss/</docs>
    <generator>BSA Feed Generator</generator>
    <managingEditor>sureshn@cybermedia.co.in</managingEditor>
    <webMaster>webmasterciol@cybermedia.co.in</webMaster>
    <item>
      <title>Obesity drug market to reach $600 mn by 2018</title>
      <link>http://www.biospectrumasia.com/content/100310OTH12209.asp</link>
      <description>According to the forecast of independent business analyst, the anti-diabetics market will be worth $37 billion by 2018 up from $20 billion in 2008. This rapid market expansion presents significant opportunities for pharmaceutical companies that are a</description>
      <pubDate>3/10/2010 3:27:41 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/100310OTH12209.asp</guid>
    </item>
    <item>
      <title>GSK looks for acquisitions in India, says Andrew Witty</title>
      <link>http://www.biospectrumasia.com/content/100310IND12208.asp</link>
      <description>GSK is keen on acquiring an Indian pharma company. GSK CEO Andrew Witty who is in India said the company is scouting for a possible Indian target to strengthen its business here</description>
      <pubDate>3/10/2010 1:45:48 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/100310IND12208.asp</guid>
    </item>
    <item>
      <title>GE Healthcare expands manufacturing operations in India</title>
      <link>http://www.biospectrumasia.com/content/100310IND12207.asp</link>
      <description>GE Healthcare, the $17 bn healthcare division of General Electric Company, has announced the expansion of its Bangalore, India, manufacturing operations in its endeavor to locally serve its customers and leveraging the price-value equation in India</description>
      <pubDate>3/10/2010 1:33:03 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/100310IND12207.asp</guid>
    </item>
    <item>
      <title>Sanofi-aventis, Merck tie up to form animal health divison</title>
      <link>http://www.biospectrumasia.com/content/100310OTH12206.asp</link>
      <description>Sanofi-aventis and Merck have announced that Sanofi-aventis has plans to combine Merial with Intervet/Schering-Plough, Mercks Animal Health business. The new joint venture will be equally-owned by Merck and Sanofi-aventis</description>
      <pubDate>3/10/2010 12:40:27 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/100310OTH12206.asp</guid>
    </item>
    <item>
      <title>International Symposium on Alcohol fuels starts in Delhi</title>
      <link>http://www.biospectrumasia.com/content/100310IND12205.asp</link>
      <description>The 34th edition of the International Symposium on Alcohol Fuels (ISAF XVIII) is being held in New Delhi between March 9-12, 2010. The main theme of the event is ''Innovation for Local and Global Sustainability of Alcohol Fuels''</description>
      <pubDate>3/10/2010 12:24:20 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/100310IND12205.asp</guid>
    </item>
    <item>
      <title>Millipore launches ICW-3000 system</title>
      <link>http://www.biospectrumasia.com/content/100310SGP12204.asp</link>
      <description>Millipore, one of the leading providers of technologies, tools and services for the global life science industry, has introduced ICW-3000 water purification system. The new system produces a constant and reliable source of ultrapure water for Dionex</description>
      <pubDate>3/10/2010 11:51:45 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/100310SGP12204.asp</guid>
    </item>
    <item>
      <title>Abbott acquires Facet Biotech for $450 mn</title>
      <link>http://www.biospectrumasia.com/content/100310OTH12203.asp</link>
      <description>Abbott is buying Facet Biotech for $450 million enhancing its early- and mid-stage pharmaceutical pipeline. The acquisition brings access to biologics in two key therapeutic areas, immunology and oncology</description>
      <pubDate>3/10/2010 11:41:26 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/100310OTH12203.asp</guid>
    </item>
    <item>
      <title>LCT''s encapsulation device gets registration in Russia</title>
      <link>http://www.biospectrumasia.com/content/100310NZD12202.asp</link>
      <description>Cell implant company Living Cell Technologies announced that its subsidiary LCT Biomedical has received registration of the encapsulation device as a delivery system in Russia</description>
      <pubDate>3/10/2010 11:12:46 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/100310NZD12202.asp</guid>
    </item>
    <item>
      <title>Teijin Pharma launches drug for Hyperuricemia in Gout Pati</title>
      <link>http://www.biospectrumasia.com/content/100310TWN12201.asp</link>
      <description>Teijin Pharma has launched TMX-67 (febuxostat), a novel drug for the treatment of hyperuricemia in patients with gout in Europe</description>
      <pubDate>3/10/2010 10:53:00 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/100310TWN12201.asp</guid>
    </item>
    <item>
      <title>Thai researchers develop allergy test kit for domestic animals</title>
      <link>http://www.biospectrumasia.com/content/090310THA12200.asp</link>
      <description>The technology breakthrough helps to reduce the amount of wait time by clinic physicians, quicker analysis of animal health symptoms, and cost savings for both the clinic and pet owners.</description>
      <pubDate>3/9/2010 3:46:25 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/090310THA12200.asp</guid>
    </item>
    <item>
      <title>The urgent need for qualified transportation providers in clinical research</title>
      <link>http://www.biospectrumasia.com/content/090310OTH12199.asp</link>
      <description>According to a recent study conducted by the UK''s MHRA, a staggering 43 percent of critical and major product deficiencies are related to ineffective temperature control and monitoring during storage and transportation</description>
      <pubDate>3/9/2010 1:22:56 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/090310OTH12199.asp</guid>
    </item>
    <item>
      <title>Eli Lilly to acquire Pfizer''s animal health biz in Europe</title>
      <link>http://www.biospectrumasia.com/content/090310OTH12198.asp</link>
      <description>Elanco, the animal health division of Eli Lilly said that the company has signed an agreement to acquire the European rights to a portfolio of certain Pfizer Animal Health products</description>
      <pubDate>3/9/2010 12:11:41 PM</pubDate>
      <guid>http://www.biospectrumasia.com/content/090310OTH12198.asp</guid>
    </item>
    <item>
      <title>Australia, China research collaboration doubled: TR</title>
      <link>http://www.biospectrumasia.com/content/090310AUS12196.asp</link>
      <description>A study from Thomson Reuters released today shows broadening international collaboration in the research of Australia and, to a lesser degree, New Zealand, over the past 10 years</description>
      <pubDate>3/9/2010 11:45:05 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/090310AUS12196.asp</guid>
    </item>
    <item>
      <title>Xcellerex, Humacyte to develop single-use tech for transplantation</title>
      <link>http://www.biospectrumasia.com/content/090310OTH12195.asp</link>
      <description>Humacyte and Xcellerex have entered into an initial strategic collaboration for Xcellerex to develop a novel manufacturing process that will enable the production of Humacyte''s lead regenerative medicine product using Xcellerex''s XDR single use</description>
      <pubDate>3/9/2010 11:03:44 AM</pubDate>
      <guid>http://www.biospectrumasia.com/content/090310OTH12195.asp</guid>
    </item>
  </channel>
</rss>